North America RNAi Technology Market – Size, Outlook, Trends and Forecast (2024

North America RNAi Technology Market - Size

Study Period

2018 - 2030

Base Year For Estimation

2023

Forecast Data Period

2024-2030

Historical Data Period

2018-2021

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

RNAi technology is a process which inhibits gene expression by neutralising the targeted mRNA. In the fields of pharmaceutical and biotechnology, RNAi technology will help to improve technologies in therapeutics and drug discovery. RNAi is commonly known as co-suppression or quelling.

North America RNAi Technology Market Segments Size & Growth:

North America RNAi Technology Market is accounted for $XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth by increasing research activities in RNAi technology mainly in cancer. However, reimbursement and FDA regulations hinder the growth of the North America RNAi technology market.

North America RNAi Technology Market Segments Share:

North America RNAi Technology Market is categorised into by application which consists of agriculture, drug discovery, research & development, and therapeutics. Within the RNAi technology

North America RNAi Technology Market - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

market, the therapeutic segment is further classified by oncology, heart ailment, neurodegenerative disease, respiratory disorders, autoimmune hepatitis, and metabolic disorders. Research and development have the most significant share due to increase in research developments in RNAi technology mainly on chronic diseases, such as cancer.

By Geography, United States is dominating the North America RNAi technology market, and the growth in North America is mainly attributed because of considerable investments in R&D activities and advancements in therapies. Furthermore, Mexico is witnessing the fastest growth during the forecast period, due to rapidly increasing pharmaceutical infrastructure and the government initiatives.

North America RNAi Technology Market Segments Trends:

In recent research, Thermo Fisher Scientific Inc. has developed a new technology to reduce the gene function by mammalian gene expression.
In January 2017, Qiagen N.V. has acquired OmicSoft Corporation to access multi-omics data management solutions.
In August 2017, Thermo Fisher Scientific Inc. has acquired Patheon N.V. to expand services in pharmaceutical and biotechnology firms.

North America RNAi Technology Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

Qiagen NV
Silence Therapeutics
Arcturus Therapeutics
Benitec Biopharma Ltd
Takara Bio Inc. (Clonetch)

management solutions. In August

You can also purchase parts of this report. Do you want to check out a section wise price list

North America RNAi Technology Market - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.